BiondVax Pharmaceuticals ...

NASDAQ: BVXV · Real-Time Price · USD
1.36
0.01 (0.74%)
At close: Sep 06, 2023, 9:59 PM

BiondVax Pharmaceuticals Balance Sheet Statement

Financials in ILS. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
14.07M 54.04M
Short-Term Investments
n/a n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
n/a 444K
Receivables
110K 306K
Inventory
n/a n/a
Other Current Assets
n/a n/a
Total Current Assets
14.37M 55.05M
Property-Plant & Equipment
12.7M 44.11M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
12.7M 44.55M
Total Assets
27.07M 99.6M
Account Payables
716K 3.11M
Deferred Revenue
n/a n/a
Short-Term Debt
382K 773K
Other Current Liabilities
1.24M 3.33M
Total Current Liabilities
2.34M 7.21M
Long-Term Debt
21.16M 68.96M
Other Long-Term Liabilities
5.33M 95K
Total Long-Term Liabilities
26.49M 69.06M
Total Liabilities
28.83M 76.27M
Total Debt
21.54M 69.74M
Common Stock
n/a n/a
Retained Earnings
-115.83M -364.77M
Comprehensive Income
-2.01M n/a
Shareholders Equity
-1.76M 23.33M
Total Investments
n/a n/a